We also reminded commenters that, in response to the commenters' concerns expressed in rulemaking for the CY 2020 GPCI update, we included more detailed steps in the final report, Final Report for the CY 2020 Update of GPCIs and MP RVUs for the Medicare Phys Fee Sched_v19Feb2020, which is available on the CMS website under the downloads section of the CY 2020 PFS final rule to assist interested parties in navigating these data
In controlled workflows, this format is used for solution prep where sterility, labeling and repeatable handling characteristics are important
It is the difference between a regulated medical product and an unregulated substance with unknown contents
For details on these policies, see section IV.B.5.b
In practice, its significant
It ensures the medication remains uncontaminated and safe for use